Your browser doesn't support javascript.
loading
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease.
Kahaly, George J; Dolman, Peter J; Wolf, Jan; Giers, Bert C; Elflein, Heike M; Jain, Amy P; Srinivasan, Ashok; Hadjiiski, Lubomir; Jordan, David; Bradley, Elizabeth A; Stan, Marius N; Eckstein, Anja; Pitz, Susanne; Vorländer, Christian; Wester, Sara T; Nguyen, John; Tucker, Nancy; Sales-Sanz, Marco; Feldon, Steven E; Nelson, Christine C; Hardy, Isabelle; Abia-Serrano, Maravillas; Tedeschi, Philip; Janes, Jonathan M; Xu, Jing; Vue, Peter; Macias, William L; Douglas, Raymond S.
  • Kahaly GJ; Department of Medicine I, Johannes Gutenberg University (JGU) Medical Center, 55131 Mainz, Germany.
  • Dolman PJ; Department of Ophthalmology and Visual Sciences, Vancouver General Hospital, University of British Columbia, Vancouver, BC V5Z 3N9, Canada.
  • Wolf J; Department of Medicine I, Johannes Gutenberg University (JGU) Medical Center, 55131 Mainz, Germany.
  • Giers BC; Department of Ophthalmology, Johannes Gutenberg University (JGU) Medical Center, 55131 Mainz, Germany.
  • Elflein HM; Department of Ophthalmology, Johannes Gutenberg University (JGU) Medical Center, 55131 Mainz, Germany.
  • Jain AP; Department of Ophthalmology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
  • Srinivasan A; Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Hadjiiski L; Department of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Jordan D; Department of Ophthalmology, University of Ottawa Eye Institute, Ottawa, ON K1H 8L6, Canada.
  • Bradley EA; Department of Ophthalmology, Mayo Clinic, Rochester, MN 55905, USA.
  • Stan MN; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN 55905, USA.
  • Eckstein A; Department of Ophthalmology, University Hospital Essen, 45147 Essen, Germany.
  • Pitz S; Department of Ophthalmology, Orbitazentrum, Bürgerhospital Frankfurt, 60318 Frankfurt, Germany.
  • Vorländer C; Department of Endocrine Surgery, Bürgerhospital Frankfurt, 60318 Frankfurt, Germany.
  • Wester ST; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Nguyen J; Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV 26506, USA.
  • Tucker N; Toronto Retina Institute, Toronto, ON M5T 3L9, Canada.
  • Sales-Sanz M; Department of Ophthalmology, University Hospital Ramon y Cajal, 28034 Madrid, Spain.
  • Feldon SE; Department of Ophthalmology, Flaum Eye Institute, University of Rochester, Rochester, NY 14642, USA.
  • Nelson CC; W.K. Kellogg Eye Center, University of Michigan, Ann Arbor, MI 48105, USA.
  • Hardy I; Department of Ophthalmology, University of Montreal, Montreal, QC H3T 1J4, Canada.
  • Abia-Serrano M; Department of Ophthalmology, Bellvitge University Hospital, 08907 Barcelona, Spain.
  • Tedeschi P; Immunovant, Inc., New York, NY 10018, USA.
  • Janes JM; Immunovant, Inc., New York, NY 10018, USA.
  • Xu J; Immunovant, Inc., New York, NY 10018, USA.
  • Vue P; Immunovant, Inc., New York, NY 10018, USA.
  • Macias WL; Immunovant, Inc., New York, NY 10018, USA.
  • Douglas RS; Department of Ophthalmology, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
J Clin Endocrinol Metab ; 108(12): 3122-3134, 2023 Nov 17.
Article en En | MEDLINE | ID: mdl-37390454

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Exoftalmia / Oftalmopatía de Graves Tipo de estudio: Clinical_trials Límite: Humans / Newborn Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Exoftalmia / Oftalmopatía de Graves Tipo de estudio: Clinical_trials Límite: Humans / Newborn Idioma: En Año: 2023 Tipo del documento: Article